Healio Rheumatology


The following articles appeared in the print edition of HEALIO RHEUMATOLOGY.

Table of Contents
Cover Story

Checkpoint Checkmate: Adverse Event Management for Checkpoint Inhibitors

Drug Pipeline

Pfizer Initiates Phase 3 Trial of Tofacitinib for Ankylosing Spondylitis

FDA Allows for Expanded Marketing of 23andMe to Include Medication Metabolism

FDA Expands Approval of Rituxan for Two Rare Forms of Vasculitis

FDA Approves Hyrimoz, Third Humira Biosimilar

FDA Approves Gamifant, the First Drug to Treat Hemophagocytic Lymphohistiocytosis


Social Media as a Creative/Disruptive Force in Rheumatology (or Why I Now Tweet)

Leonard H. Calabrese, DO

Education Lab

AWIR 2nd Annual Immunology Bootcamp Part 1: TNF and IL-6 Biology and Inhibitors

FDA News

FDA Warns 465 Websites Selling Unapproved Opioids, Drugs for Cancer, HIV

FDA Approves Dsuvia for Acute Pain Management


Crowdsourcing Health Care: Is the Customer Always Right?


Draft Criteria for IgG4-related Disease Diagnosis Emphasize Multi-factorial Presentation

Draft Criteria for Large-vessel Vasculitis Support Key Role for Imaging

ACR Announces Draft Guidelines for Reproductive Health Management

Health Care Updates

Trump Proposes Allowing Medicare to Base Drug Costs on Prices Abroad

In the Journals

Rheumatology Fellows Unsure How to Engage in Health Policy, Advocacy

Patient Education Does Not Improve Pain Outcomes

Improved Quadricep Strength Linked to Better Function in Women With OA

Physical Therapies Underused Following Total Knee Replacement

Poor JIA Prognosis More Likely Among Maori, Pacific Island Children

PsA Disease Activity in Women Highest at 6 Months Postpartum

Adherence, Persistence Low in Veterans With RA Who Escalate to Triple Therapy

On-demand Sildenafil Not Superior to Placebo for Raynaud’s Syndrome

Back Pain in Teens Tied to Smoking, Drinking Alcohol, Anxiety, Depression

US Leads Developed Nations in Drug Overdose Deaths

Dual VA, Medicare Enrollment Linked to Overlapping Opioid, Benzodiazepine Prescriptions

No Increased Adverse Events, Health Care Use in Treat-to-target Strategies for RA

Text Message Reminders Improve Methotrexate Adherence in RA

Meeting News

Hematopoietic Stem Cell Transplantation for Scleroderma Durable After 6 to 11 Years

Vascular Ultrasound Highly Sensitive, Specific for Large-vessel GCA Diagnosis

Recurrent Lupus Nephritis Less Frequent After Kidney Transplant

No Correlation Between Race, Poverty and Risk for TKR Failure

Failure to Achieve Serum Urate Target Increases Death Risk in Gout

Comorbidity in Patients With RA Affects Disease Activity

IgG Antiphospholipid Antibodies Linked to Heart Attack

Hard-to-treat Patients With Sclerosis Respond to Stem Cell Transplantation

Half of Patients With RA Do Not Modify Therapies to Meet Treat-to-target Guidelines

B-cell Receptor Clones Predict High Risk for Rheumatoid Arthritis

All Gains in Infliximab Biosimilar Use Have Gone to Inflectra

Experts Debate Hydroxychloroquine Dosing Guidelines in Lupus

'Culturally Competent' Online Resource Raises Lupus Awareness in At-risk Populations

Opioid Use Common Before Total Joint Replacement Surgery

Biologic Tapering Successful, Cost-effective in Low-activity RA

Children With JIA Have Higher Rate of Adverse Childhood Experiences

Q&A With Healio Rheumatology

Augmenting the Risk: Breast Implants Linked to Rheumatic, Autoimmune Diseases

Trend Watch

Legacy Prescribing Appears Common in Primary Care

CMS Proposes Revisions to Improve Medicaid, CHIP Managed Care

Psychiatric Disorders, CVD, IBD More Prevalent in Psoriasis With PsA

CIRT: Methotrexate Fails to Prevent Atherosclerotic Events

Few Rheumatic Adverse Events From Immune Checkpoint Inhibitors Require Discontinuation